NIH-Led Venture Launches Online Portal for Alzheimer’s Research
March 9, 2015 in News
On Wednesday, an NIH-led public-private partnership launched an online portal to foster data sharing and analysis among Alzheimer’s disease researchers, Health Data Management reports (Slabodkin, Health Data Management, 3/9).
The Accelerating Medicines Partnership is a joint project among:
- 10 biopharmaceutical companies;
- NIH; and
- Various not-for-profits.
The partnership is managed by the Foundation for the NIH (NIH release, 3/4).
The AMP-Alzheimer’s Disease Knowledge Portal, which was developed by Seattle-based Sage Bionetworks, aims to accelerate the development of Alzheimer’s disease treatments.
The portal will store big data generated by multidisciplinary academic groups over the next five years. The academic teams will work with bioinformaticists, data scientists and drug discovery experts from Sage Bionetworks to integrate molecular and clinical data from more than 2,000 brain samples using advanced analytical approaches. The first set of data was released with the launch of the portal.
Officials said that the use of data posted to the AMP-AD Knowledge Portal would not be embargoed in an effort to increase the transparency, sharing and analysis of large and complex biomedical datasets (Heath Data Management, 3/9).
According to an NIH release, researchers believe this approach will accelerate the development of predictive models of Alzheimer’s disease and help identify the clinical signs and symptoms of the disease (NIH release, 3/4).